Lambert-Eaton Myasthenic Syndrome (LEMS) operates as a rare autoimmune neuromuscular disorder. The immune system attacks the voltage-gated calcium channels located in nerve endings.

This specific attack severely restricts communication between nerves and muscles. LEMS shares some physical symptoms with MG but affects a fundamentally different biological process. Consequently, this distinct syndrome requires highly specialized diagnosis and treatment protocols.